Analyzing Avivagen (OTCMKTS:VIVXF) and Canopy Growth (NASDAQ:CGC)

Avivagen (OTCMKTS:VIVXF) and Canopy Growth (NASDAQ:CGC) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability and earnings.

Analyst Ratings

This is a summary of current ratings and price targets for Avivagen and Canopy Growth, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avivagen	0	0	0	0	0.00
Canopy Growth	2	3	2	0	2.00

Given Avivagen’s higher probable upside, equities research analysts clearly believe Avivagen is more favorable than Canopy Growth.

Insider and Institutional Ownership

3.3% of Canopy Growth shares are held by institutional investors. 2.1% of Avivagen shares are held by company insiders. Comparatively, 0.2% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Avivagen and Canopy Growth”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avivagen	N/A	N/A	N/A	($0.04)	N/A
Canopy Growth	$225.65 million	2.06	-$429.86 million	($1.30)	-0.88

Avivagen has higher earnings, but lower revenue than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Avivagen, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Avivagen and Canopy Growth’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Avivagen	N/A	N/A	N/A
Canopy Growth	-94.39%	-46.85%	-28.95%

Summary

Avivagen beats Canopy Growth on 6 of the 10 factors compared between the two stocks.

About Avivagen

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

About Canopy Growth

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.